结直肠癌的外科手术期间免疫检查点抑制:最近的进展和未来的方向

Jiao-Ting Chen1, Yu-Wen Zhou1, Ting-Rui Han2

  • 1Department of Colorectal Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

Frontiers in immunology
|November 29, 2023
PubMed
概括

术后免疫疗法对结肠直肠癌 (CRC) 患者有希望,改善了那些微卫星高度不稳定/缺陷不匹配修复 (MSI-H/dMMR) 患者的治疗结果,甚至有些人患有不匹配修复能力/微卫星稳定 (pMMR/MSS) 疾病.